Eunjin Kwon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Eunjin Kwon has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Ji-Soo Kim
Department of Neurology, Seoul National University College of Medicine, Seoul, South Korea.
10 shared publications - Seong-Hae Jeong
Department of Neurology, Chungnam National University School of Medicine, Daejeon, Korea
10 shared publications - Hyo-Jung Kim
Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam, South Korea
7 shared publications - Jeong-Yoon Choi
Dizziness Center, Clinical Neuroscience Center, Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea
6 shared publications - Eun Ji Kim
Department of Neurology, Chungnam National University Hospital, Daejeon, Korea
5 shared publications - Hye Seon Jeong
Department of Neurology, Chungnam National University Hospital, Chungnam National University College of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon 35015, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 3 February 2026
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 17 (1) , e70219
Association of Sarcopenia and Lower Bone Density With Positional Vertigo in the Morning: Insights From a Nationwide Survey
Background: This study aimed to identify associations of sarcopenia, obesity and low bone mineral density (BMD) with morning positional vertigo (PV) and to examine whether these associations differ according to vestibular function status in a nationally representative sample of Korean adults. Methods: We analysed data from 8512 adults aged ≥ 40 years (50.03% women, mean ± standard error [SE] = 54.06 ± 0.19) who participated in the Korean National Health and Nutrition Examination Survey 2008–2010. Morning PV was defined as severe vertigo when turning in bed or rising in the morning within the past year. Vestibular impairment was assessed using the modified Romberg test (eyes closed, standing on a compliant foam surface). Participants were classified into three groups: controls (no dizziness), morning PV with normal Romberg test results and morning PV with abnormal Romberg test results (suggesting vestibular dysfunction). Body composition—including appendicular skeletal muscle mass, fat mass and BMD—was measured. Sarcopenia was defined according to the Asian Working Group for Sarcopenia 2019 criteria, and abnormal BMD was defined as T‐score < 1.0. Weighted multinomial logistic regression analyses were adjusted for age, sex, income, comorbidities, lifestyle and psychosocial variables. Results: The weighted 1‐year prevalence of morning PV was 12.58% (95% confidence interval [CI], 11.38–13.89). Abnormal Romberg performance, indicating vestibular dysfunction, was present in 0.96% of all survey respondents and in 7.66% of those with morning PV. Participants with vestibular‐impaired morning PV were older (mean age ± SE = 66.47 ± 1.49), predominantly women, and had higher rates of sarcopenia (38.33%) and low BMD (86.39%) than controls. In adjusted models, sarcopenia independently predicted vestibular‐impaired morning PV (odds ratio [OR], 1.94; 95% CI, 1.14–3.29; p = 0.014). Sensitivity analysis restricted to current morning PV confirmed the association between sarcopenia and vestibular impairment (OR, 2.97; 95% CI, 1.08–8.12; p = 0.035) and demonstrated that lower BMD (minimum T‐score) was inversely associated with vestibular dysfunction (OR, 0.49; 95% CI, 0.25–0.99; p = 0.046). Conclusions: Morning PV is common among middle‐aged and older adults and is associated with systemic frailty markers, particularly sarcopenia and bone loss, in the presence of vestibular dysfunction. These associations were more pronounced in older adults, suggesting a vestibulo‐musculoskeletal interaction that may contribute to balance impairment and functional decline with aging. Screening for sarcopenia and bone health, along with vestibular and lifestyle interventions, may help reduce recurrent vertigo and improve functional aging.
- 3 February 2026
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 17 (1) , e70219
Open AccessAssociation of Sarcopenia and Lower Bone Density With Positional Vertigo in the Morning: Insights From a Nationwide Survey
Background: This study aimed to identify associations of sarcopenia, obesity and low bone mineral density (BMD) with morning positional vertigo (PV) and to examine whether these associations differ according to vestibular function status in a nationally representative sample of Korean adults. Methods: We analysed data from 8512 adults aged ≥ 40 years (50.03% women, mean ± standard error [SE] = 54.06 ± 0.19) who participated in the Korean National Health and Nutrition Examination Survey 2008–2010. Morning PV was defined as severe vertigo when turning in bed or rising in the morning within the past year. Vestibular impairment was assessed using the modified Romberg test (eyes closed, standing on a compliant foam surface). Participants were classified into three groups: controls (no dizziness), morning PV with normal Romberg test results and morning PV with abnormal Romberg test results (suggesting vestibular dysfunction). Body composition—including appendicular skeletal muscle mass, fat mass and BMD—was measured. Sarcopenia was defined according to the Asian Working Group for Sarcopenia 2019 criteria, and abnormal BMD was defined as T‐score < 1.0. Weighted multinomial logistic regression analyses were adjusted for age, sex, income, comorbidities, lifestyle and psychosocial variables. Results: The weighted 1‐year prevalence of morning PV was 12.58% (95% confidence interval [CI], 11.38–13.89). Abnormal Romberg performance, indicating vestibular dysfunction, was present in 0.96% of all survey respondents and in 7.66% of those with morning PV. Participants with vestibular‐impaired morning PV were older (mean age ± SE = 66.47 ± 1.49), predominantly women, and had higher rates of sarcopenia (38.33%) and low BMD (86.39%) than controls. In adjusted models, sarcopenia independently predicted vestibular‐impaired morning PV (odds ratio [OR], 1.94; 95% CI, 1.14–3.29; p = 0.014). Sensitivity analysis restricted to current morning PV confirmed the association between sarcopenia and vestibular impairment (OR, 2.97; 95% CI, 1.08–8.12; p = 0.035) and demonstrated that lower BMD (minimum T‐score) was inversely associated with vestibular dysfunction (OR, 0.49; 95% CI, 0.25–0.99; p = 0.046). Conclusions: Morning PV is common among middle‐aged and older adults and is associated with systemic frailty markers, particularly sarcopenia and bone loss, in the presence of vestibular dysfunction. These associations were more pronounced in older adults, suggesting a vestibulo‐musculoskeletal interaction that may contribute to balance impairment and functional decline with aging. Screening for sarcopenia and bone health, along with vestibular and lifestyle interventions, may help reduce recurrent vertigo and improve functional aging.
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (40)
Dietary Inflammation and Chronic Dizziness With Imbalance in Middle-Aged and Older Adults: A Nationally Representative Study
Jeong SH, et al. J Korean Med Sci. 2026 Oct;41:e257. https://doi.org/10.3346/jkms.2026.41.e257
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (40)
Open AccessDietary Inflammation and Chronic Dizziness With Imbalance in Middle-Aged and Older Adults: A Nationally Representative Study
Jeong SH, et al. J Korean Med Sci. 2026 Oct;41:e257. https://doi.org/10.3346/jkms.2026.41.e257
- Open Access
- 15 June 2025
- Published by The Korean Balance Society in Research in Vestibular Science
- Vol. 24 (2) , 89-97
Understanding body composition in vestibular disorders: where do we stand? A narrative review
Vestibular disorders significantly affect balance and spatial orientation, yet symptom severity varies greatly among patients with similar levels of vestibular impairment. Emerging evidence suggests that differences in body composition, specifically muscle mass, fat distribution, and bone density, may play crucial roles in modulating vestibular symptoms and overall functional outcomes. Sarcopenia, characterized by reduced muscle mass and strength, and conditions like osteopenia and osteoporosis have been independently linked to increased dizziness and imbalance, particularly in older adults. Experimental studies in animal models indicate vestibular system involvement in regulating muscle and bone metabolism via gravity-induced mechanisms, emphasizing vestibular-dependent molecular pathways. However, current clinical evidence remains preliminary, and further well-designed prospective studies are needed to clarify these relationships. This review synthesizes available insights into the interplay between vestibular function and body composition, highlights its clinical implications, and advocates for integrated management strategies, while emphasizing the importance of ongoing rigorous research.
- 15 June 2025
- Published by The Korean Balance Society in Research in Vestibular Science
- Vol. 24 (2) , 89-97
Open AccessUnderstanding body composition in vestibular disorders: where do we stand? A narrative review
Vestibular disorders significantly affect balance and spatial orientation, yet symptom severity varies greatly among patients with similar levels of vestibular impairment. Emerging evidence suggests that differences in body composition, specifically muscle mass, fat distribution, and bone density, may play crucial roles in modulating vestibular symptoms and overall functional outcomes. Sarcopenia, characterized by reduced muscle mass and strength, and conditions like osteopenia and osteoporosis have been independently linked to increased dizziness and imbalance, particularly in older adults. Experimental studies in animal models indicate vestibular system involvement in regulating muscle and bone metabolism via gravity-induced mechanisms, emphasizing vestibular-dependent molecular pathways. However, current clinical evidence remains preliminary, and further well-designed prospective studies are needed to clarify these relationships. This review synthesizes available insights into the interplay between vestibular function and body composition, highlights its clinical implications, and advocates for integrated management strategies, while emphasizing the importance of ongoing rigorous research.
- 14 March 2025
- Published by SAGE Publications in Journal of Vestibular Research
- Vol. 35 (4) , 193-204
Clinical features of secondary BPPV: A nation-wide multicenter study
Background: Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder, and its prevalence is substantial. While primary BPPV has been well studied, the understanding of secondary BPPV is still limited. Objective: To investigate the prevalence and clinical characteristics of secondary BPPV in a national multicenter retrospective analysis. Methods: The study involved a retrospective analysis of medical records from 17 institutions across South Korea, between January and June 2022. We evaluated clinical features, presumed etiologies, involvement of semicircular canals, response to canalith repositioning procedures (CRPs), presence of residual dizziness, recurrence, and results of auditory and vestibular function tests for both primary and secondary BPPV cases. Results: Of the total 1363 BPPV cases, 14.5% (198 patients) were categorized as secondary BPPV. The most prevalent etiology for secondary BPPV was head trauma. Secondary BPPV was associated with a higher prevalence of comorbidities including diabetes and inner ear diseases. Patients with secondary BPPV demonstrated more frequent involvement of multiple semicircular canals, necessitated a greater number of CRPs for resolution, and experienced a higher incidence of residual dizziness compared to primary BPPV cases. Furthermore, secondary BPPV patients exhibited more frequent abnormalities in auditory and vestibular function tests. Conclusions: Secondary BPPV accounts for a significant proportion of BPPV cases, with distinct clinical characteristics compared to primary BPPV.
- 14 March 2025
- Published by SAGE Publications in Journal of Vestibular Research
- Vol. 35 (4) , 193-204
Clinical features of secondary BPPV: A nation-wide multicenter study
Background: Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder, and its prevalence is substantial. While primary BPPV has been well studied, the understanding of secondary BPPV is still limited. Objective: To investigate the prevalence and clinical characteristics of secondary BPPV in a national multicenter retrospective analysis. Methods: The study involved a retrospective analysis of medical records from 17 institutions across South Korea, between January and June 2022. We evaluated clinical features, presumed etiologies, involvement of semicircular canals, response to canalith repositioning procedures (CRPs), presence of residual dizziness, recurrence, and results of auditory and vestibular function tests for both primary and secondary BPPV cases. Results: Of the total 1363 BPPV cases, 14.5% (198 patients) were categorized as secondary BPPV. The most prevalent etiology for secondary BPPV was head trauma. Secondary BPPV was associated with a higher prevalence of comorbidities including diabetes and inner ear diseases. Patients with secondary BPPV demonstrated more frequent involvement of multiple semicircular canals, necessitated a greater number of CRPs for resolution, and experienced a higher incidence of residual dizziness compared to primary BPPV cases. Furthermore, secondary BPPV patients exhibited more frequent abnormalities in auditory and vestibular function tests. Conclusions: Secondary BPPV accounts for a significant proportion of BPPV cases, with distinct clinical characteristics compared to primary BPPV.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (46) , e303
Altered Body Composition in Dizziness and Vestibular Dysfunction: Insights From the Korean National Health and Nutrition Examination Survey
Kim EJ, et al. J Korean Med Sci. 2025 Oct;40:e303. https://doi.org/10.3346/jkms.2025.40.e303
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (46) , e303
Open AccessAltered Body Composition in Dizziness and Vestibular Dysfunction: Insights From the Korean National Health and Nutrition Examination Survey
Kim EJ, et al. J Korean Med Sci. 2025 Oct;40:e303. https://doi.org/10.3346/jkms.2025.40.e303
- Open Access
- 21 June 2024
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (8) , 5704-5706
Correction to: Central paroxysmal positional nystagmus mimicking posterior canal benign paroxysmal positional vertigo in pontine infarction: a case report and literature review
- 21 June 2024
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (8) , 5704-5706
Open AccessCorrection to: Central paroxysmal positional nystagmus mimicking posterior canal benign paroxysmal positional vertigo in pontine infarction: a case report and literature review
- Open Access
- 15 June 2024
- Published by The Korean Balance Society in Research in Vestibular Science
- Vol. 23 (2) , 46-52
Serum otolin-1 level is specific to benign paroxysmal positional vertigo
Objectives: When we see patients with a history of positional vertigo (PV), many patients are diagnosed with benign paroxysmal PV (BPPV) by performing a typical history and nystagmus during a positioning maneuver. Recent studies reported that Otolin-1 can be detected in serum and that its levels significantly increase with age and BPPV. Herein, we tried to study the relationship between serum otolin-1 level and the other clinical aspects in patients with PV.Methods: We measured the serum levels of otolin-1 in 117 BPPV patients (82 females; age range, 43–92 years; mean age±standard deviation [SD], 68.5±10.5 years), referred to as the BPPV group; and nine patients (seven females; age range, 61–79 years; mean age±SD, 66.9±5.9 years) with PV not compatible with BPPV, referred to as another PV group. All the BPPV patients were treated with an appropriate canal repositioning maneuver followed by blood sampling within 1 week. Results: The serum levels of otolin-1 were higher in the BPPV group than in another PV group (mean±SD, 350.1±319.1 pg/mL vs. 183.6±134.1 pg/mL, respectively; p=0.037). However, there were no differences in both laboratory findings (serum vitamin D, C-telopeptide of type collagen, and bone mineral density) and clinical findings (age, sex, vertigo duration, ear disease, ear symptom, migraine, motion sickness, trauma, and previous BPPV) between these two groups. Conclusions: Serum otolin-1 level could help predict the current existence of BPPV in patients with PV. However, further validation studies are needed.
- 15 June 2024
- Published by The Korean Balance Society in Research in Vestibular Science
- Vol. 23 (2) , 46-52
Open AccessSerum otolin-1 level is specific to benign paroxysmal positional vertigo
Objectives: When we see patients with a history of positional vertigo (PV), many patients are diagnosed with benign paroxysmal PV (BPPV) by performing a typical history and nystagmus during a positioning maneuver. Recent studies reported that Otolin-1 can be detected in serum and that its levels significantly increase with age and BPPV. Herein, we tried to study the relationship between serum otolin-1 level and the other clinical aspects in patients with PV.Methods: We measured the serum levels of otolin-1 in 117 BPPV patients (82 females; age range, 43–92 years; mean age±standard deviation [SD], 68.5±10.5 years), referred to as the BPPV group; and nine patients (seven females; age range, 61–79 years; mean age±SD, 66.9±5.9 years) with PV not compatible with BPPV, referred to as another PV group. All the BPPV patients were treated with an appropriate canal repositioning maneuver followed by blood sampling within 1 week. Results: The serum levels of otolin-1 were higher in the BPPV group than in another PV group (mean±SD, 350.1±319.1 pg/mL vs. 183.6±134.1 pg/mL, respectively; p=0.037). However, there were no differences in both laboratory findings (serum vitamin D, C-telopeptide of type collagen, and bone mineral density) and clinical findings (age, sex, vertigo duration, ear disease, ear symptom, migraine, motion sickness, trauma, and previous BPPV) between these two groups. Conclusions: Serum otolin-1 level could help predict the current existence of BPPV in patients with PV. However, further validation studies are needed.
- Open Access
- 15 June 2024
- Published by The Korean Balance Society in Research in Vestibular Science
- Vol. 23 (2) , 37-45
Prevalence and preferred medication for vestibular migraine in Menière’s disease: a multicenter retrospective cohort study in Korea
Objectives: The aim of this study is to categorize headaches associated with definite Menière’s disease (MD) according to diagnostic criteria, to determine their prevalence, and to investigate the preferred medication across participating centers.Methods: Patients diagnosed with definite MD at 17 university hospitals in otolaryngology or neurology departments in Korea between January 1, 2021 to December 31, 2021 were retrospectively included. Data on the presence of accompanying vestibular migraine (VM), migraine or non-migraine headaches, and clinical information were collected. A survey was conducted to assess preferences for treatment drugs for vertigo and headache control in MD patients with headache.Results: A total of 435 definite MD patients were included, with a mean age of 57.0±14.9 years. Among them, 135 (31.0%) had accompanying headaches, of whom 48 (11.0% of all definite MD patients) could be diagnosed with VM. The prevalence of comorbid VM (definite and probable) was significantly higher in females (41 of 288, 14.2%) than in males (7 of 147, 4.8%) (p 0.05). Benzodiazepines, antihistamines, and antiemetics were mainly preferred for acute vertigo control, while nonsteroidal anti-inflammatory drugs, acetaminophen, and triptans were preferred for acute headache control, and topiramate, propranolol, and calcium channel blockers were mainly preferred for headache prevention.Conclusions: VM is not uncommon in patients with definite MD in Korea. Further research is needed to understand the differences in headache prevalence and preferred medications across different centers.
- 15 June 2024
- Published by The Korean Balance Society in Research in Vestibular Science
- Vol. 23 (2) , 37-45
Open AccessPrevalence and preferred medication for vestibular migraine in Menière’s disease: a multicenter retrospective cohort study in Korea
Objectives: The aim of this study is to categorize headaches associated with definite Menière’s disease (MD) according to diagnostic criteria, to determine their prevalence, and to investigate the preferred medication across participating centers.Methods: Patients diagnosed with definite MD at 17 university hospitals in otolaryngology or neurology departments in Korea between January 1, 2021 to December 31, 2021 were retrospectively included. Data on the presence of accompanying vestibular migraine (VM), migraine or non-migraine headaches, and clinical information were collected. A survey was conducted to assess preferences for treatment drugs for vertigo and headache control in MD patients with headache.Results: A total of 435 definite MD patients were included, with a mean age of 57.0±14.9 years. Among them, 135 (31.0%) had accompanying headaches, of whom 48 (11.0% of all definite MD patients) could be diagnosed with VM. The prevalence of comorbid VM (definite and probable) was significantly higher in females (41 of 288, 14.2%) than in males (7 of 147, 4.8%) (p 0.05). Benzodiazepines, antihistamines, and antiemetics were mainly preferred for acute vertigo control, while nonsteroidal anti-inflammatory drugs, acetaminophen, and triptans were preferred for acute headache control, and topiramate, propranolol, and calcium channel blockers were mainly preferred for headache prevention.Conclusions: VM is not uncommon in patients with definite MD in Korea. Further research is needed to understand the differences in headache prevalence and preferred medications across different centers.
- 29 March 2024
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (6) , 3672-3677
Central paroxysmal positional nystagmus mimicking posterior canal benign paroxysmal positional vertigo in pontine infarction: a case report and literature review
- 29 March 2024
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (6) , 3672-3677
Central paroxysmal positional nystagmus mimicking posterior canal benign paroxysmal positional vertigo in pontine infarction: a case report and literature review
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Clinical Neurology
- Vol. 20 (3) , 342-344
Antisaccades in Spinocerebellar Ataxia Type 17 With Middle Cerebellar Peduncle Hyperintensities Without Hot-Cross-Bun Sign
Lee HI, et al. J Clin Neurol. 2024 May;20(3):342-344. https://doi.org/10.3988/jcn.2023.0397
- 1 January 2024
- Published by XMLink in Journal of Clinical Neurology
- Vol. 20 (3) , 342-344
Open AccessAntisaccades in Spinocerebellar Ataxia Type 17 With Middle Cerebellar Peduncle Hyperintensities Without Hot-Cross-Bun Sign
Lee HI, et al. J Clin Neurol. 2024 May;20(3):342-344. https://doi.org/10.3988/jcn.2023.0397